Medical Grade Hyaluronic Acid Market

The global Medical Grade Hyaluronic Acid Market is Estimated at USD 1.54 Billion in 2024 and is projected to reach a value of USD 3.26 Billion by 2034 at a CAGR (Compound Annual Growth Rate) of 7.6% between 2024 and 2034.

Premium Insights:

Medical Grade Hyaluronic Acid (HA) is highly effective in fighting inflammatory skin conditions and promoting skin healing, and is used in products and industries such as pharmaceuticals, cosmetics, aesthetics, and orthopedics, among others. Hyaluronic acid, also known as hyaluronan or hyaluronate, is a naturally occurring biopolymer in the human body, and is integral to various physiological processes such as hydration, joint lubrication, and tissue repair. HA used in cosmetics and personal care and pharmaceutical products to moisten eyes, enhance skin health, lubricate joints, and improve elasticity of tissue and skin. HA nanogel can solubilize insoluble drugs, suppress aggregation and denaturation of biopharmaceuticals, and retain drug activity. Used as a viscosupplement in osteoarthritis treatments, medical grade HA lubricates joints offers relief from pain. In dermatology and cosmetic surgery, it is used as injectable dermal fillers to alleviate wrinkles, correct tissue volume loss, enhance suppleness or elasticity of skin, and improve skin tone and health. Medical-grade hyaluronic acid plays a very crucial role in the development of advanced therapies in tissue engineering, wound healing, and cell therapies. It also serves to accelerate wound recovery process and reduce scarring. HA plays a major role in tissue engineering and in creation of scaffolds to support cell growth, differentiation, and integration with host tissue. HA-based scaffolds remain the preferred option owing to biocompatibility, biodegradability, and ability to mimic the Extracellular Matrix (ECM). These scaffolds provide a 3D microenvironment that facilitates cell attachment and proliferation and HA scaffolds can be customized for tissue repair and to support chondrocytes growth, which are the cells responsible for producing the cartilage matrix. Major focus is being directed to this application, as a result of increasing prevalence of degenerative joint diseases such as Osteoarthritis (OA), and the importance of HA in the regeneration of damaged cartilage and restoration of joint function.

Pharmaceutical grade HA is also used as an Active Pharmaceutical Ingredient (API) or excipient for drugs and medical devices, including medical grade HA and injection grade HA, in ophthalmic preparations, in-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler. Medical Grade Hyaluronic Acid is produced by extraction of the compound from microbial fermentation or animal sources, which is then purified in compliance with relevant processes and regulations. HA is produced more widely or on large-scale using bacterial fermentation, and this method is performed with genetically modified bacteria strains. HA is also extracted from animal and human tissues, some of which include comb of rooster and human umbilical cord. It is also extracted from eggshell membrane following separation of the membrane from the shell, using mechanical or chemical process.

Production of plant-based and synthetic HA has also been gaining traction owing to ethical and safety concerns related to animal-derived HA and associated risks and safety aspects. A major factor driving evolution in various production techniques and approaches in advancements in nanotechnology, which has enabled development of novel HA delivery system such as nanoparticles for targeted delivery in therapeutic applications. Biocompatibility, biodegradability, and minimal side effects are also factors driving demand for medical grade HA, as well as increasing use in development of more advanced drug delivery systems, regenerative medicine, cosmetics treatments and applications, and therapies, among others.

Top Market Drivers and Trends:

High Effectiveness in Skin Care Products: Demand for medical grade HA is significantly high in skin care products due to use of high-quality ingredients and ability for strong formulations to be designed to provide effective results. Also, products with this ingredient usually have a stronger concentration of active ingredients than Over-the-Counter (OTC) products, and therefore can be more effective for treatment of skin conditions such as acne, wrinkles, and sun damage.

Focus on Aesthetics and Age-Related Conditions and Treatments: An increasing consumer base is seeking approaches, therapies, treatments, and products and solutions to address age-related conditions, beauty enhancement, and improve physical appearance and aesthetics, and this is more prominent in developed countries. The global population is aging steadily, and this is also resulting in rising prevalence of age-related diseases and medical and physical conditions.

Increased Spending on Personal Appearance and Beauty: Increased spending capacity among consumers of varying ages, availability of various treatments and therapies for enhancing beauty and aesthetics, as well as awareness regarding new and novel approaches and technologies to address age-related changes and disfigurement, and skin ailments or damage caused by medical conditions or drugs, accidents, trauma, etc., has been driving demand for aesthetic and dermatological treatments such as dermal fillers and wrinkle-reducing injections, among numerous others. In addition, age brings along increasing prevalence of joint conditions, such as osteoarthritis for instance, has been driving rising demand for HA as a viscosupplement for joint lubrication and pain relief and pain management.

Technological Advancements in Production: Extraction and purification techniques and approaches have been significantly enhanced by technological advancements in the recent past. This has enabled higher HA extraction and production of purified yields with enhanced safety and efficacy. Such advances are also enabling development of more innovative delivery systems, such as HA-based nanoparticles, for therapeutic applications beyond traditional uses.

Favorable Policies and Healing Potential: Favorable healthcare policies and guidelines are encouraging adoption of various medical treatments and procedures, including cosmetic procedures and treatments and therapies. Awareness regarding ability of medical grade HA to improve wound healing and aid in tissue regeneration, while accelerating wound recovery with reduced scarring, are also key factors driving acceptance of available solutions, products, and procedures in the market.

Preference for Minimally-Invasive Cosmetic Procedures: Shift towards minimally-invasive cosmetic procedures and HA-based treatments in the aesthetics industry have been gaining traction, driven by high visibility and rising awareness regarding the benefits and outcomes. Increase in efficacy of HA in cosmetic products and favorable outcomes of aesthetic enhancement procedures and expansion of skincare, haircare, and personal care product portfolios by manufacturers using HA as a key ingredient due to the versatility and biocompatibility properties are also trends driving market growth.

Restraining Factor Insights

Potential Side Effects of Strong Formulations: Prescription skin care products are typically strong formulations and can cause side effects such as dryness, increased sensitivity to Ultraviolet (UV) rays, inflammation, pain, and itching related to HA-based products. Hesitation or reluctance is particularly high when considering injections or other direct applications. In the current scenario, consumers are increasingly accessing social media platforms, sharing product reviews, creating vlogs and blogs, influence video content, and providing feedback on products in real time. Potential adverse effects, or reactions to products or ingredients can be conveyed across the globe to consumers and either attract a consumer base towards a product or solution, or have a major negative impact.

High Cost and Limited Insurance Cover: The high costs associated with medical-grade hyaluronic acid treatments can have a significant impact on preference. Costs can be high for procedures such as dermal fillers and viscosupplements, and this is especially a major barrier for consumers in certain economies or regions, and particularly stringent if lacking insurance coverage for aesthetic and cosmetic treatments.

Regulatory Challenges and Approvals: Securing approval for use of medical grade HA in new products and procedures can be lengthy and complex, especially in developed economies. This can delay products from reaching to consumer, result in increased end costs, restrict availability of new HA products and treatments in certain market, and overall dampen revenues. Such delays can also raise trust issues regarding safety and efficacy of product or solution, and have negative impact on brand.

Market Saturation and Emergence of Alternatives: Presence of a number of companies offering medical-grade HA as well as a range of services and products has led to saturation. Availability of variety and range of end-products can cause hesitation or reluctance owing to uncertainity supported by availability of potential counterfeit products and safety and health risks. In addition, a number of alternative or competing solutions and products emerging in the market such as botulinum toxin and other injectable fillers can divert potential customers away from HA-based options.

Market Opportunities

Diversification of Product Portfolio: Developing and offering innovative HA formulations for specific applications such as combination treatments with other active ingredients for enhanced efficacy in aesthetics or joint health can enable companies to diversifying respective product portfolios. A key segment to explore avenues in personalized medicine and creation of customized HA-based treatments, specifically in dermatology and orthopedics, can help to address patient-specific needs.

Expansion into Untapped Markets: Companies can explore opportunities in emerging markets where healthcare spending has been increasing and consumer base for minimally-invasive treatments and procedures is trending. Understanding and recognizing this trend can be crucial to leverage opportunities for expansion into emerging markets, and this is applicable to developing economies. Entering into strategic partnerships and engaging in mergers and acquisitions can also create avenues in such markets, and investment in R&D for new HA applications and products with domestic or local needs in focus, including cost factor, can present lucrative revenue opportunities and enable setting up of local facilities and building brand recognition or image.

Segment Insights:

By Form:

The injectable segment among the form segments accounted for largest revenue share in 2023, and is expected to continue to maintain dominance over the forecast period. Rising demand for dermal fillers in minimally invasive cosmetic treatments and increasing usage of medical grade HA in medical applications in orthopedics such as for joint lubrication and pain relief, coupled with continuous innovation in product formulations to enhance efficacy and safety of treatments are some of the key factors supporting revenue growth of this segment.

By Source:

The microbial fermentation segment accounted for largest revenue share in 2023, and the trend is expected to continue. This steady growth rate is attributed to high preference for medical grade HA produced from microbial fermentation as opposed to animal-derived HA with risk of source contaminants. Also, this method enables production of consistently high-quality and pure HA, allows for sustainable production, aligns with eco-friendly and ethical sourcing practices, as well as offers flexibility to cater to varying demands and address wider needs, which is key to promoting adoption in various applications such as aesthetics, orthopedics, and ophthalmology, among others.

By Application:

Among the application segments, the aesthetic treatments segment is expected to register fastest revenue growth rate over the forecast period. Preference for minimally invasive cosmetic procedures, skin care, anti-aging treatments, and wrinkle reduction treatments and procedures, dermal fillers, and facial rejuvenation are some key factors supporting demand for medical grade HA.

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

By End-User:

Among the end user segments, the hospitals and clinics segment is expected to account for the largest revenue share over the forecast period. This projection is supported by the role hospitals and clinics play as the primary setting for administering HA-based treatments, particularly in aesthetics, orthopedics, and ophthalmology. The availability of skilled healthcare professionals and advanced medical infrastructure facilitates the adoption of HA treatments in these facilities, and also, increasing preference for minimally invasive procedures performed in hospitals and clinics drives the demand for HA-based products.

Regional Landscape:

The North America Medical Grade Hyaluronic Acid market currently leads among the other regional markets in terms of revenue share contribution to the global market. Factors such as high healthcare expenditure and robust demand for aesthetic and orthopedic treatments, especially in the US are some key factors supporting growth of the market in the region. Europe Medical Grade Hyaluronic Acid market revenue growth is supported majorly by contribution from Germany, France, and the UK. These countries have well-established healthcare infrastructure and large consumer base and patient pools with high awareness regarding advantages and benefits of minimally-invasive enhancements, procedures, and treatments in aesthetics and cosmetics. The market in Asia Pacific is expected to register significant revenue growth over the forecast period with introduction of new and novel products into China and Japan, which are key markets for medical grade HA. Factors such as rapidly aging populations, increased healthcare spending, and rising awareness regarding efficacy and advantages of HA-based treatments are expected to continue to support growth of the market in the region.

Hyaluronic Acid Market Competitive Landscape:

Company List:

• Allergan Aesthetics
• Galderma
• Sanofi
• Anika Therapeutics
• L'ORÉAL
• Merz Pharma
• Nestlé Skin Health
• Lifecore Biomedical
• Stanley Pharmaceuticals
• Contipro
• Laboratoires Vivacy
• Fidia Farmaceutici S.P.A.
• BioScience GmbH
• Hyaltech
• Shiseido

The competitive landscape in the global Medical Grade Hyaluronic Acid (HA) market is intense, with established pharmaceutical and biotechnology companies competing with some new entrants specializing in specific and customized products and offerings. This is resulting in a number of established players focusing on innovation and product differentiation and improving formulations to enhance efficiency and outcomes, as well as to expand HA applications. Partnerships and collaborations with research institutions and healthcare sector, as well as with other players in the market are some strategies observed. Diversification of product portfolio to leverage varying consumer or end-use requirements, capitalizing on vegan-ingredient trend, adopting production processes to ensure compliance with regulatory standards, and innovating and integrating technologies to ensure high-quality production and yields are some other trends in the market.

Recent Developments:

• August 27, 2024: Allergan Aesthetics, which is an AbbVie company, announced launch of SkinMedica HA5 Hydra Collagen Replenish + Restore Hydrator. The next-generation hydration product is specifically designed to deliver hydration, visible plumpness, and radiance to facial skin.
• January 22, 2024: Galderma announced receiving approval from Health Canada for Restylane SHAYPE, which is a hyaluronic acid injectable designed for temporary augmentation of the chin region. The product is engineered to build and shape on bone with deep injection for a bone-mimicking effect.
• January 9, 2024: A study published in Experimental Dermatology examined how cross-linked hyaluronic acid (CL-HA) injections could reverse age-related skin changes. This research emphasized the potential role of hyaluronic acid in dermatological treatments aimed at reversing the signs of aging.

The global Medical Grade Hyaluronic Acid market can be categorized as Category, Application, and Region.

Frequently Asked Questions:

Q: What is the global Medical Grade Hyaluronic Acid market estimation and projection for the forecast period?

A: The global Medical Grade Hyaluronic Acid market is estimated to be valued at USD 1.54 Billion in 2024, and projected to reach USD 3.26 Billion in 2034.

Q: Which are the major companies are included in the global hyaluronic acid market report?

A: Major companies in the market report are Allergan Aesthetics, Galderma, Sanofi, Anika Therapeutics, L'ORÉAL, Merz Pharma, Nestlé Skin Health, Lifecore Biomedical, Stanley Pharmaceuticals, Contipro, Laboratoires Vivacy, Fidia Farmaceutici S.P.A., BioScience GmbH, Hyaltech, Shiseido

Q: What is the projected revenue CAGR of the global Medical Grade Hyaluronic Acid market over the forecast period?

A: The global hyaluronic acid market is expected to register a CAGR of 7.6% between 2024 and 2034.

Q: What are some key factors driving revenue growth of the Medical Grade Hyaluronic Acid market?

A: Factors such as high effectiveness in skin care products with medical grade HA, high focus on aesthetics and age-related conditions and treatments, increased spending on personal appearance and beauty, and technological advancements in production, extraction, and purification techniques and approaches with HA, favorable regulations and policies, preference for minimally-invasive cosmetic procedures.

Q: Which regional market accounts for largest revenue share?

A: North America accounted for largest revenue share in the global Medical Grade Hyaluronic Acid market in 2023.